Mar 2020

Case study: NICE Liaison Group

In March 2018, we organised and hosted a workshop entitled ‘NICE Guidance: from on the website to on the ground.’ The purpose of the workshop was to learn about and share ideas on optimising the use of NICE guidance in Wales, from dissemination to implementation.

Mar 2020

Update statement: Coronavirus disease (COVID-19)

In light of the current COVID-19 outbreak, we have been reviewing the meetings held to support Health Technology Wales (HTW) appraisal and Guidance processes.

Mar 2020

Case study: FreeStyle Libre

We appraised evidence on the FreeStyle Libre flash glucose monitoring system for diabetes, in response to FreeStyle Libre becoming available on the NHS Drugs Tariff. We published Guidance in November 2018.

Mar 2020

Statement: Coronavirus disease (COVID-19)

Health Technology Wales (HTW) is aware of the situation regarding the new coronavirus disease (COVID-19).

Mar 2020

Case study: Harmonising HTA

In 2018, International Network of Agencies for Health Technology Assessment (INAHTA) members identified ‘hot topics’ that were in need of position statements from a public agency perspective.

Mar 2020

Case study: Pacemaker telemonitoring for heart failure

The Welsh Cardiac Network requested an appraisal on pacemaker telemonitoring (remote monitoring) for the management of heart failure.

Mar 2020

Health Technology Wales and NICE announce strategic collaboration

Health Technology Wales (HTW) and the National Institute for Health and Care Excellence (NICE) have formally committed to work together to enhance their independent and authoritative Guidance on non-medicine technologies.

Feb 2020

Health Technology Wales launches two new e-publications

We’re pleased to announce two new e-publications that will give you regular HTW news and updates straight to your inbox: HTW Quarterly and HTW Guidance Alerts.

Report published: Developing the HTW Audit Function to Assess the Adoption of Guidance across Wales

This is a critical step in the spread of technological innovations and has resulted in an agreed process to facilitate and monitor; routine consideration, uptake, (de)commissioning and implementation of evidence-based guidance in NHS Wales.